Trial
NCT00816504
Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Northwell Health
Collaborators
Medical College of Wisconsin
Condition
Focal Segmental Glomerulosclerosis
Intervention
Galactose
Why stopped
Under additional IRB Review
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-09-07